Deciphera Pharmaceuticals Inc (DCPH)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: DCPH Exchange: NSM


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2020-01-06 2020-01-02 PS Planned sale

Taylor Michael Douglas

2,731 -57.3%
59.40
162,229 USD 		2,731 -57.3% 59.40 162,229 USD
2020-01-06 2020-01-02 PS Planned sale

Taylor Michael Douglas

33,045 -87.4%
58.08
1,919,300 USD 		33,045 -87.4% 58.08 1,919,300 USD
2020-01-06 2020-01-02 PS Planned sale

Taylor Michael Douglas

55,768 -59.6%
57.50
3,206,677 USD 		55,768 -59.6% 57.50 3,206,677 USD
2020-01-06 2020-01-02 PS Planned sale

Bristol James Arthur

300 -100.0%
61.87
18,561 USD 		300 -100.0% 61.87 18,561 USD
2020-01-06 2020-01-02 PS Planned sale

Bristol James Arthur

365 -54.9%
59.38
21,675 USD 		365 -54.9% 59.38 21,675 USD
2020-01-06 2020-01-02 PS Planned sale

Bristol James Arthur

5,347 -88.9%
58.08
310,567 USD 		5,347 -88.9% 58.08 310,567 USD
2020-01-06 2020-01-02 PS Planned sale

Bristol James Arthur

9,541 -61.3%
57.51
548,665 USD 		9,541 -61.3% 57.51 548,665 USD
2020-01-06 2020-01-02 PS Planned sale

Kelly Thomas Patrick

Chief Financial Officer
100 -100.0%
62.25
6,225 USD 		100 -100.0% 62.25 6,225 USD
2020-01-06 2020-01-02 PS Planned sale

Kelly Thomas Patrick

Chief Financial Officer
200 -66.7%
59.48
11,896 USD 		200 -66.7% 59.48 11,896 USD
2020-01-06 2020-01-02 PS Planned sale

Kelly Thomas Patrick

Chief Financial Officer
1,981 -86.8%
58.16
115,219 USD 		1,981 -86.8% 58.16 115,219 USD
2020-01-06 2020-01-02 PS Planned sale

Kelly Thomas Patrick

Chief Financial Officer
5,360 -70.1%
57.54
308,408 USD 		5,360 -70.1% 57.54 308,408 USD
2020-01-06 2020-01-02 PS Planned sale

Morl Christopher John

Chief Business Officer
400 -100.0%
62.25
24,900 USD 		400 -100.0% 62.25 24,900 USD
2020-01-06 2020-01-02 PS Planned sale

Morl Christopher John

Chief Business Officer
800 -66.7%
61.58
49,266 USD 		800 -66.7% 61.58 49,266 USD
2020-01-06 2020-01-02 PS Planned sale

Morl Christopher John

Chief Business Officer
800 -40.0%
60.58
48,463 USD 		800 -40.0% 60.58 48,463 USD
2020-01-06 2020-01-02 PS Planned sale

Morl Christopher John

Chief Business Officer
2,103 -51.3%
59.48
125,087 USD 		2,103 -51.3% 59.48 125,087 USD
2020-01-06 2020-01-02 PS Planned sale

Morl Christopher John

Chief Business Officer
3,529 -46.2%
58.38
206,039 USD 		3,529 -46.2% 58.38 206,039 USD
2020-01-06 2020-01-02 PS Planned sale

Morl Christopher John

Chief Business Officer
8,505 -52.7%
57.74
491,117 USD 		8,505 -52.7% 57.74 491,117 USD
2019-12-26 2019-12-23 S Sale

Kelly Thomas Patrick

Chief Financial Officer

Officer
40,000 -100.0%
68.21
2,728,368 USD 		40,000 -100.0% 68.21 2,728,368 USD
2019-12-13 2019-12-12 PS Planned sale

Morl Christopher John

Chief Business Officer

Officer
15,034 -100.0%
60.00
902,040 USD 		15,034 -100.0% 60.00 902,040 USD
2019-12-13 2019-12-12 PS Planned sale

Flynn Daniel Lee

Chief Scientific Officer

Officer
31,029 -46.5%
60.00
1,861,740 USD 		31,029 -46.5% 60.00 1,861,740 USD
2019-12-11 2019-12-10 PS Planned sale

Morl Christopher John

Chief Business Officer

Officer
11,647 -100.0%
55.00
640,585 USD 		11,647 -100.0% 55.00 640,585 USD
2019-12-11 2019-12-10 PS Planned sale

Flynn Daniel Lee

Chief Scientific Officer

Officer
93,930 -79.3%
55.00
5,166,150 USD 		93,930 -79.3% 55.00 5,166,150 USD
2019-12-11 2019-12-10 PS Planned sale

Flynn Daniel Lee

Chief Scientific Officer

Officer
28,822 -54.1%
55.00
1,585,210 USD 		28,822 -54.1% 55.00 1,585,210 USD
2019-12-11 2019-12-09 PS Planned sale

Morl Christopher John

Chief Business Officer

Officer
3,387 -100.0%
55.00
186,285 USD 		3,387 -100.0% 55.00 186,285 USD
2019-12-11 2019-12-09 PS Planned sale

Flynn Daniel Lee

Chief Scientific Officer

Officer
30,175 -55.2%
55.00
1,659,625 USD 		30,175 -55.2% 55.00 1,659,625 USD
2019-12-05 2019-12-03 PS Planned sale

Morl Christopher John

Chief Business Officer

Officer
15,034 -100.0%
50.00
751,763 USD 		15,034 -100.0% 50.00 751,763 USD
2019-11-13 2019-11-11 PS Planned sale

Flynn Daniel Lee

Chief Scientific Officer

Officer
143,185 -85.4%
48.01
6,874,870 USD 		143,185 -85.4% 48.01 6,874,870 USD
2019-11-13 2019-11-08 PS Planned sale

Flynn Daniel Lee

Chief Scientific Officer

Officer
9,742 -28.5%
48.00
467,616 USD 		9,742 -28.5% 48.00 467,616 USD
2019-11-05 2019-11-01 PS Planned sale

Bristol James Arthur

25,000 -100.0%
45.07
1,126,823 USD 		25,000 -100.0% 45.07 1,126,823 USD
2019-11-05 2019-11-01 PS Planned sale

Taylor Michael Douglas

7,500 -100.0%
45.02
337,646 USD 		7,500 -100.0% 45.02 337,646 USD
2019-10-30 2019-10-28 PS Planned sale

Flynn Daniel Lee

Chief Scientific Officer
29,820 -54.9%
40.00
1,192,800 USD 		29,820 -54.9% 40.00 1,192,800 USD
2019-10-30 2019-10-28 PS Planned sale

Kelly Thomas Patrick

Chief Financial Officer
3,750 -100.0%
40.00
150,010 USD 		3,750 -100.0% 40.00 150,010 USD
2019-09-23 2019-09-19 PS Planned sale

Martin Daniel C.

Chief Commercial Officer
3,000 -15.0%
35.56
106,688 USD 		3,000 -15.0% 35.56 106,688 USD
2019-09-13 2019-09-11 PS Planned sale

Kelly Thomas Patrick

Chief Financial Officer
3,090 -100.0%
35.43
109,468 USD 		3,090 -100.0% 35.43 109,468 USD
2019-09-13 2019-09-11 PS Planned sale

Kelly Thomas Patrick

Chief Financial Officer
8,160 -50.0%
34.80
283,972 USD 		8,160 -50.0% 34.80 283,972 USD
2019-09-13 2019-09-11 PS Planned sale

Taylor Michael Douglas

6,151 -100.0%
35.41
217,789 USD 		6,151 -100.0% 35.41 217,789 USD
2019-09-13 2019-09-11 PS Planned sale

Taylor Michael Douglas

16,349 -72.7%
34.81
569,043 USD 		16,349 -72.7% 34.81 569,043 USD
2019-09-05 2019-09-03 PS Planned sale

Taylor Michael Douglas

7,500 -100.0%
36.26
271,975 USD 		7,500 -100.0% 36.26 271,975 USD
2019-08-19 2019-08-16 S Sale

New Leaf Venture Management III, L.L.C.

Major owner
28,626 -1.4%
37.01
1,059,586 USD 		28,626 -1.4% 37.01 1,059,586 USD
2019-08-19 2019-08-16 S Sale

New Leaf Venture Management III, L.L.C.

Major owner
75,974 -3.7%
36.54
2,776,341 USD 		75,974 -3.7% 36.54 2,776,341 USD
2019-08-19 2019-08-16 S Sale

New Leaf Venture Management III, L.L.C.

Major owner
26,108 -1.4%
37.01
966,382 USD 		26,108 -1.4% 37.01 966,382 USD
2019-08-19 2019-08-16 S Sale

New Leaf Venture Management III, L.L.C.

Major owner
69,292 -3.7%
36.54
2,532,158 USD 		69,292 -3.7% 36.54 2,532,158 USD
2019-08-19 2019-08-15 S Sale

New Leaf Venture Management III, L.L.C.

Major owner
78,450 -3.7%
36.09
2,831,347 USD 		78,450 -3.7% 36.09 2,831,347 USD
2019-08-19 2019-08-15 S Sale

New Leaf Venture Management III, L.L.C.

Major owner
71,550 -3.7%
36.09
2,582,318 USD 		71,550 -3.7% 36.09 2,582,318 USD
2019-08-13 2019-08-13 PS Planned sale

Flynn Daniel Lee

Chief Scientific Officer

Officer
25,000 -27.2%
42.90
1,072,500 USD 		25,000 -27.2% 42.90 1,072,500 USD
2019-08-13 2019-08-13 PS Planned sale

Flynn Daniel Lee

Chief Scientific Officer

Officer
29,712 -54.8%
41.33
1,227,911 USD 		29,712 -54.8% 41.33 1,227,911 USD
2019-08-13 2019-08-13 PS Planned sale

Flynn Daniel Lee

Chief Scientific Officer

Officer
93,395 -63.3%
40.26
3,760,344 USD 		93,395 -63.3% 40.26 3,760,344 USD
2019-08-13 2019-08-13 PS Planned sale

Taylor Michael Douglas

Non-Executive Director
4,000 -100.0%
42.49
169,978 USD 		4,000 -100.0% 42.49 169,978 USD
2019-08-13 2019-08-13 PS Planned sale

Taylor Michael Douglas

Non-Executive Director
1,300 -24.5%
41.77
54,303 USD 		1,300 -24.5% 41.77 54,303 USD
2019-08-13 2019-08-13 PS Planned sale

Taylor Michael Douglas

Non-Executive Director
13,767 -72.2%
40.50
557,558 USD 		13,767 -72.2% 40.50 557,558 USD
2019-08-13 2019-08-13 PS Planned sale

Taylor Michael Douglas

Non-Executive Director
3,433 -15.3%
39.47
135,502 USD 		3,433 -15.3% 39.47 135,502 USD
2019-08-13 2019-08-13 PS Planned sale

Kelly Thomas Patrick

Chief Financial Officer

Officer
400 -100.0%
42.92
17,167 USD 		400 -100.0% 42.92 17,167 USD
2019-08-13 2019-08-13 PS Planned sale

Kelly Thomas Patrick

Chief Financial Officer

Officer
3,586 -90.0%
42.25
151,521 USD 		3,586 -90.0% 42.25 151,521 USD
2019-08-13 2019-08-13 PS Planned sale

Kelly Thomas Patrick

Chief Financial Officer

Officer
7,264 -64.6%
40.69
295,568 USD 		7,264 -64.6% 40.69 295,568 USD
2019-08-13 2019-08-13 PS Planned sale

Bristol James Arthur

Non-Executive Director
100 -100.0%
42.90
4,290 USD 		100 -100.0% 42.90 4,290 USD
2019-08-13 2019-08-13 PS Planned sale

Bristol James Arthur

Non-Executive Director
700 -87.5%
42.05
29,435 USD 		700 -87.5% 42.05 29,435 USD
2019-08-13 2019-08-13 PS Planned sale

Bristol James Arthur

Non-Executive Director
12,687 -94.1%
40.50
513,843 USD 		12,687 -94.1% 40.50 513,843 USD
2019-08-13 2019-08-13 PS Planned sale

Bristol James Arthur

Non-Executive Director
11,513 -46.1%
39.24
451,798 USD 		11,513 -46.1% 39.24 451,798 USD
2019-06-21 2019-06-19 PS Planned sale

Kelly Thomas Patrick

Chief Financial Officer
177 -100.0%
25.00
4,425 USD 		177 -100.0% 25.00 4,425 USD
2019-06-05 2019-06-03 PS Planned sale

Kelly Thomas Patrick

Chief Financial Officer
2,100 -100.0%
25.20
52,927 USD 		2,100 -100.0% 25.20 52,927 USD
2019-05-23 2019-05-22 PS Planned sale

Kelly Thomas Patrick

Chief Financial Officer
100 -100.0%
25.00
2,500 USD 		100 -100.0% 25.00 2,500 USD
2019-05-23 2019-05-21 PS Planned sale

Kelly Thomas Patrick

Chief Financial Officer
1,373 -100.0%
25.07
34,419 USD 		1,373 -100.0% 25.07 34,419 USD
2019-05-03 2019-05-01 PS Planned sale

Kelly Thomas Patrick

Chief Financial Officer
13,500 -100.0%
22.93
309,524 USD 		13,500 -100.0% 22.93 309,524 USD
2019-02-20 2019-02-19 PS Planned sale

Kelly Thomas Patrick

Chief Financial Officer

Officer
1,500 -100.0%
30.00
45,000 USD 		1,500 -100.0% 30.00 45,000 USD
2019-02-19 2019-02-19 PS Planned sale

Taylor Michael Douglas

President and CEO

Executive Director
3,997 -100.0%
30.00
119,913 USD 		3,997 -100.0% 30.00 119,913 USD
2019-02-19 2019-02-15 PS Planned sale

Taylor Michael Douglas

President and CEO

Executive Director
4,934 -100.0%
28.01
138,193 USD 		4,934 -100.0% 28.01 138,193 USD
2019-02-19 2019-02-15 PS Planned sale

Bristol James Arthur

Non-Executive Director
17,782 -100.0%
28.04
498,604 USD 		17,782 -100.0% 28.04 498,604 USD
2019-02-19 2019-02-14 PS Planned sale

Taylor Michael Douglas

President and CEO

Executive Director
500 -100.0%
28.00
14,000 USD 		500 -100.0% 28.00 14,000 USD
2019-02-19 2019-02-14 PS Planned sale

Bristol James Arthur

Non-Executive Director
1,101 -100.0%
28.01
30,842 USD 		1,101 -100.0% 28.01 30,842 USD
2019-02-14 2019-02-13 PS Planned sale

Bristol James Arthur

Non-Executive Director
2,922 -100.0%
28.01
81,836 USD 		2,922 -100.0% 28.01 81,836 USD
2019-02-14 2019-02-13 PS Planned sale

Taylor Michael Douglas

President and CEO

Executive Director
2,666 -100.0%
28.00
74,657 USD 		2,666 -100.0% 28.00 74,657 USD
2019-02-14 2019-02-12 PS Planned sale

Bristol James Arthur

Non-Executive Director
600 -100.0%
28.00
16,801 USD 		600 -100.0% 28.00 16,801 USD
2019-02-14 2019-02-12 PS Planned sale

Taylor Michael Douglas

President and CEO

Executive Director
200 -100.0%
28.00
5,600 USD 		200 -100.0% 28.00 5,600 USD
2019-02-07 2019-02-05 PS Planned sale

Bristol James Arthur

Non-Executive Director
2,595 -100.0%
28.02
72,704 USD 		2,595 -100.0% 28.02 72,704 USD
2019-02-07 2019-02-05 PS Planned sale

Taylor Michael Douglas

President and CEO

Executive Director
1,700 -100.0%
28.01
47,611 USD 		1,700 -100.0% 28.01 47,611 USD